Pharmaceuticals

Global Cystic Fibrosis Drugs Market Insights, Forecast to 2025

  • QYR2790502
  • 128 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In 2017, the global Cystic Fibrosis Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Cystic Fibrosis Drugs market based on company, product type, application and key regions.

This report studies the global market size of Cystic Fibrosis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cystic Fibrosis Drugs in these regions.

This research report categorizes the global Cystic Fibrosis Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter\'s Five Forces Analysis.

The various contributors involved in the value chain of Cystic Fibrosis Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Cystic Fibrosis Drugs include

Actavis

F. Hoffmann-La Roche

Gilead Sciences

Novartis

Vertex Pharmaceuticals

Abbott

Anthera Pharmaceuticals

Arcturus Therapeutics

Boehringer Ingelheim

Chiesi Farmaceutici

Corbus Pharmaceuticals

Genzyme

Insmed

Johnson & Johnson

Merck Sharp & Dohme

Neovii Biotech

Novo Nordisk

PharmaSwiss

Pharmaxis

Proteostasis Therapeutics

PTC Therapeutics

United Medical

Venus Remedies

Market Size Split by Type

Oral

Injection

Market Size Split by Application

Hospitals

Clinics

Other

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Cystic Fibrosis Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Cystic Fibrosis Drugs market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Cystic Fibrosis Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cystic Fibrosis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Cystic Fibrosis Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cystic Fibrosis Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cystic Fibrosis Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Cystic Fibrosis Drugs Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Type

1.4.2 Oral

1.4.3 Injection

1.5 Market by Application

1.5.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Application

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Cystic Fibrosis Drugs Market Size

2.1.1 Global Cystic Fibrosis Drugs Revenue 2016-2025

2.1.2 Global Cystic Fibrosis Drugs Sales 2016-2025

2.2 Cystic Fibrosis Drugs Growth Rate by Regions

2.2.1 Global Cystic Fibrosis Drugs Sales by Regions

2.2.2 Global Cystic Fibrosis Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Cystic Fibrosis Drugs Sales by Manufacturers

3.1.1 Cystic Fibrosis Drugs Sales by Manufacturers

3.1.2 Cystic Fibrosis Drugs Sales Market Share by Manufacturers

3.1.3 Global Cystic Fibrosis Drugs Market Concentration Ratio (CR5 and HHI)

3.2 Cystic Fibrosis Drugs Revenue by Manufacturers

3.2.1 Cystic Fibrosis Drugs Revenue by Manufacturers (2016-2018)

3.2.2 Cystic Fibrosis Drugs Revenue Share by Manufacturers (2016-2018)

3.3 Cystic Fibrosis Drugs Price by Manufacturers

3.4 Cystic Fibrosis Drugs Manufacturing Base Distribution, Product Types

3.4.1 Cystic Fibrosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Cystic Fibrosis Drugs Product Category

3.4.3 Date of International Manufacturers Enter into Cystic Fibrosis Drugs Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Cystic Fibrosis Drugs Sales by Type

4.2 Global Cystic Fibrosis Drugs Revenue by Type

4.3 Cystic Fibrosis Drugs Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Cystic Fibrosis Drugs Breakdown Data by Application

6 North America

6.1 North America Cystic Fibrosis Drugs by Countries

6.1.1 North America Cystic Fibrosis Drugs Sales by Countries

6.1.2 North America Cystic Fibrosis Drugs Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Cystic Fibrosis Drugs by Type

6.3 North America Cystic Fibrosis Drugs by Application

6.4 North America Cystic Fibrosis Drugs by Company

7 Europe

7.1 Europe Cystic Fibrosis Drugs by Countries

7.1.1 Europe Cystic Fibrosis Drugs Sales by Countries

7.1.2 Europe Cystic Fibrosis Drugs Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Cystic Fibrosis Drugs by Type

7.3 Europe Cystic Fibrosis Drugs by Application

7.4 Europe Cystic Fibrosis Drugs by Company

8 Asia Pacific

8.1 Asia Pacific Cystic Fibrosis Drugs by Countries

8.1.1 Asia Pacific Cystic Fibrosis Drugs Sales by Countries

8.1.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Cystic Fibrosis Drugs by Type

8.3 Asia Pacific Cystic Fibrosis Drugs by Application

8.4 Asia Pacific Cystic Fibrosis Drugs by Company

9 Central & South America

9.1 Central & South America Cystic Fibrosis Drugs by Countries

9.1.1 Central & South America Cystic Fibrosis Drugs Sales by Countries

9.1.2 Central & South America Cystic Fibrosis Drugs Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Cystic Fibrosis Drugs by Type

9.3 Central & South America Cystic Fibrosis Drugs by Application

9.4 Central & South America Cystic Fibrosis Drugs by Company

10 Middle East and Africa

10.1 Middle East and Africa Cystic Fibrosis Drugs by Countries

10.1.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Countries

10.1.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Cystic Fibrosis Drugs by Type

10.3 Middle East and Africa Cystic Fibrosis Drugs by Application

10.4 Middle East and Africa Cystic Fibrosis Drugs by Company

11 Company Profiles

11.1 Actavis

11.1.1 Actavis Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.1.4 Cystic Fibrosis Drugs Product Description

11.1.5 Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.2.4 Cystic Fibrosis Drugs Product Description

11.2.5 Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Company Description

11.3.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.3.4 Cystic Fibrosis Drugs Product Description

11.3.5 Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Company Description

11.4.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.4.4 Cystic Fibrosis Drugs Product Description

11.4.5 Recent Development

11.5 Vertex Pharmaceuticals

11.5.1 Vertex Pharmaceuticals Company Details

11.5.2 Company Description

11.5.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.5.4 Cystic Fibrosis Drugs Product Description

11.5.5 Recent Development

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Company Description

11.6.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.6.4 Cystic Fibrosis Drugs Product Description

11.6.5 Recent Development

11.7 Anthera Pharmaceuticals

11.7.1 Anthera Pharmaceuticals Company Details

11.7.2 Company Description

11.7.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.7.4 Cystic Fibrosis Drugs Product Description

11.7.5 Recent Development

11.8 Arcturus Therapeutics

11.8.1 Arcturus Therapeutics Company Details

11.8.2 Company Description

11.8.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.8.4 Cystic Fibrosis Drugs Product Description

11.8.5 Recent Development

11.9 Boehringer Ingelheim

11.9.1 Boehringer Ingelheim Company Details

11.9.2 Company Description

11.9.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.9.4 Cystic Fibrosis Drugs Product Description

11.9.5 Recent Development

11.10 Chiesi Farmaceutici

11.10.1 Chiesi Farmaceutici Company Details

11.10.2 Company Description

11.10.3 Sales, Revenue and Gross Margin of Cystic Fibrosis Drugs

11.10.4 Cystic Fibrosis Drugs Product Description

11.10.5 Recent Development

11.11 Corbus Pharmaceuticals

11.12 Genzyme

11.13 Insmed

11.14 Johnson & Johnson

11.15 Merck Sharp & Dohme

11.16 Neovii Biotech

11.17 Novo Nordisk

11.18 PharmaSwiss

11.19 Pharmaxis

11.20 Proteostasis Therapeutics

11.21 PTC Therapeutics

11.22 United Medical

11.23 Venus Remedies

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Cystic Fibrosis Drugs Raw Material

13.1.2 Cystic Fibrosis Drugs Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

List of Tables and Figures

Figure Picture of Cystic Fibrosis Drugs

Figure Global Cystic Fibrosis Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Cystic Fibrosis Drugs Production Market Share by Types (Product Category) in 2017

Figure Oral Product Picture

Table Major Manufacturers of Oral

Figure Injection Product Picture

Table Major Manufacturers of Injection

Table Global Cystic Fibrosis Drugs Market Size Growth Rate by Application 2018-2025 (K Pcs)

Figure Hospitals

Figure Clinics

Figure Other

Figure Cystic Fibrosis Drugs Report Years Considered

Figure Global Cystic Fibrosis Drugs Market Size 2016-2025 (Million US$)

Figure Global Cystic Fibrosis Drugs Sales 2016-2025 (K Pcs)

Table Global Cystic Fibrosis Drugs Market Size by Regions 2016-2025 (K Pcs) & (Million US$)

Table Global Cystic Fibrosis Drugs Sales by Regions 2016-2025 (K Pcs)

Table Global Cystic Fibrosis Drugs Sales Market Share by Regions 2016-2025

Figure Global Cystic Fibrosis Drugs Sales Market Share by Regions 2016-2025

Figure 2017 Global Cystic Fibrosis Drugs Sales Market Share by Regions

Table Global Cystic Fibrosis Drugs Revenue by Regions 2016-2025 (Million US$)

Table Global Cystic Fibrosis Drugs Revenue Market Share by Regions 2016-2025

Figure Global Cystic Fibrosis Drugs Revenue Market Share by Regions 2016-2025

Figure 2017 Global Cystic Fibrosis Drugs Revenue Market Share by Regions

Table Global Cystic Fibrosis Drugs Sales by Manufacturers (2016-2018) (K Pcs)

Table Global Cystic Fibrosis Drugs Sales Share by Manufacturers (2016-2018)

Figure Global Cystic Fibrosis Drugs Sales Share by Manufacturers in 2017

Table Cystic Fibrosis Drugs Revenue by Manufacturers (2016-2018) (Million US$)

Table Cystic Fibrosis Drugs Revenue Share by Manufacturers (2016-2018)

Figure Cystic Fibrosis Drugs Value Share by Manufacturers in 2017

Table Global Cystic Fibrosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Manufacturers Cystic Fibrosis Drugs Price (2016-2018) (USD/Pcs)

Table Cystic Fibrosis Drugs Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Cystic Fibrosis Drugs Product Category

Table Date of International Manufacturers Enter into Cystic Fibrosis Drugs Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table Global Cystic Fibrosis Drugs Sales Share by Type (2016-2025)

Figure Global Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure Global Cystic Fibrosis Drugs Sales Market Share by Type in 2017

Table Global Cystic Fibrosis Drugs Revenue by Type (2016-2025) (Million US$)

Table Global Cystic Fibrosis Drugs Revenue Share by Type (2016-2025)

Figure Global Cystic Fibrosis Drugs Revenue Market Share by Type (2016-2025)

Figure Global Cystic Fibrosis Drugs Revenue Market Share by Type in 2017

Table Cystic Fibrosis Drugs Price by Type 2013-2018 (USD/Pcs)

Table Global Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table Global Cystic Fibrosis Drugs Sales Share by Application (2016-2025)

Figure Global Sales Cystic Fibrosis Drugs Market Share by Application (2016-2025)

Figure Global Sales Cystic Fibrosis Drugs Market Share by Application (2016-2025)

Figure North America Cystic Fibrosis Drugs Sales Growth Rate 2016-2025 (K Pcs)

Figure North America Cystic Fibrosis Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table North America Cystic Fibrosis Drugs Sales by Countries (2016-2025) (K Pcs)

Table North America Cystic Fibrosis Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 North America Cystic Fibrosis Drugs Sales Market Share by Countries

Table North America Cystic Fibrosis Drugs Revenue by Countries (2016-2025) (Million US$)

Table North America Cystic Fibrosis Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 North America Cystic Fibrosis Drugs Revenue Market Share by Countries

Figure United States Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure United States Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Canada Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Canada Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Mexico Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Mexico Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table North America Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table North America Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure 2017 North America Cystic Fibrosis Drugs Market Share by Type

Table North America Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table North America Cystic Fibrosis Drugs Sales Market Share by Application (2016-2025)

Figure 2017 North America Cystic Fibrosis Drugs Market Share by Application

Table North America Cystic Fibrosis Drugs Sales by Company (2016-2018) (K Pcs)

Table North America Cystic Fibrosis Drugs Sales Market Share by Company (2016-2018)

Figure North America Cystic Fibrosis Drugs Sales Market Share by Company in 2017

Figure Europe Cystic Fibrosis Drugs Sales Growth Rate 2016-2025 (K Pcs)

Figure Europe Cystic Fibrosis Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Europe Cystic Fibrosis Drugs Sales by Countries (2016-2025) (K Pcs)

Table Europe Cystic Fibrosis Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Europe Cystic Fibrosis Drugs Sales Market Share by Countries

Table Europe Cystic Fibrosis Drugs Revenue by Countries (2016-2025) (Million US$)

Table Europe Cystic Fibrosis Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Europe Cystic Fibrosis Drugs Revenue Market Share by Countries

Figure Germany Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Germany Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (K Pcs)

Figure France Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure France Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (K Pcs)

Figure UK Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure UK Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Italy Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Italy Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Russia Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Russia Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Europe Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table Europe Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Europe Cystic Fibrosis Drugs Market Share by Type

Table Europe Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table Europe Cystic Fibrosis Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Europe Cystic Fibrosis Drugs Market Share by Application

Table Europe Cystic Fibrosis Drugs Sales by Company (2016-2018) (K Pcs)

Table Europe Cystic Fibrosis Drugs Sales Market Share by Company (2016-2018)

Figure Europe Cystic Fibrosis Drugs Sales Market Share by Company in 2017

Figure Asia Pacific Cystic Fibrosis Drugs Sales Growth Rate 2016-2025 (K Pcs)

Figure Asia Pacific Cystic Fibrosis Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Asia Pacific Cystic Fibrosis Drugs Sales by Countries (2016-2025) (K Pcs)

Table Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Countries

Table Asia Pacific Cystic Fibrosis Drugs Revenue by Countries (2016-2025) (Million US$)

Table Asia Pacific Cystic Fibrosis Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Cystic Fibrosis Drugs Revenue Market Share by Countries

Figure China Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure China Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Japan Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Japan Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Korea Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Korea Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure India Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure India Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Australia Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Australia Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Indonesia Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Indonesia Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Malaysia Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Malaysia Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Philippines Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Philippines Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Thailand Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Thailand Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Vietnam Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Vietnam Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Singapore Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Singapore Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Asia Pacific Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Asia Pacific Cystic Fibrosis Drugs Market Share by Type

Table Asia Pacific Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Asia Pacific Cystic Fibrosis Drugs Market Share by Application

Table Asia Pacific Cystic Fibrosis Drugs Sales by Company (2016-2018) (K Pcs)

Table Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Company (2016-2018)

Figure Asia Pacific Cystic Fibrosis Drugs Sales Market Share by Company in 2017

Figure Central & South America Cystic Fibrosis Drugs Sales Growth Rate 2016-2025 (K Pcs)

Figure Central & South America Cystic Fibrosis Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Central & South America Cystic Fibrosis Drugs Sales by Countries (2016-2025) (K Pcs)

Table Central & South America Cystic Fibrosis Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Central & South America Cystic Fibrosis Drugs Sales Market Share by Countries

Table Central & South America Cystic Fibrosis Drugs Revenue by Countries (2016-2025) (Million US$)

Table Central & South America Cystic Fibrosis Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Central & South America Cystic Fibrosis Drugs Revenue Market Share by Countries

Figure Brazil Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Brazil Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Argentina Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Argentina Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Central & South America Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table Central & South America Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Central & South America Cystic Fibrosis Drugs Market Share by Type

Table Central & South America Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table Central & South America Cystic Fibrosis Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Central & South America Cystic Fibrosis Drugs Market Share by Application

Table Central & South America Cystic Fibrosis Drugs Sales by Company (2016-2018) (K Pcs)

Table Central & South America Cystic Fibrosis Drugs Sales Market Share by Company (2016-2018)

Figure Central & South America Cystic Fibrosis Drugs Sales Market Share by Company in 2017

Figure Middle East and Africa Cystic Fibrosis Drugs Sales Growth Rate 2016-2025 (K Pcs)

Figure Middle East and Africa Cystic Fibrosis Drugs Revenue Growth Rate 2016-2025 (Million US$)

Table Middle East and Africa Cystic Fibrosis Drugs Sales by Countries (2016-2025) (K Pcs)

Table Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Countries

Table Middle East and Africa Cystic Fibrosis Drugs Revenue by Countries (2016-2025) (Million US$)

Table Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Cystic Fibrosis Drugs Revenue Market Share by Countries

Figure GCC Countries Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure GCC Countries Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Turkey Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Turkey Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure Egypt Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure Egypt Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Figure South Africa Cystic Fibrosis Drugs Sales Growth Rate (2016-2025) (K Pcs)

Figure South Africa Cystic Fibrosis Drugs Revenue Growth Rate (2016-2025) (Million US$)

Table Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2016-2025) (K Pcs)

Table Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Type (2016-2025)

Figure 2017 Middle East and Africa Cystic Fibrosis Drugs Market Share by Type

Table Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2016-2025) (K Pcs)

Table Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Application (2016-2025)

Figure 2017 Middle East and Africa Cystic Fibrosis Drugs Market Share by Application

Table Middle East and Africa Cystic Fibrosis Drugs Sales by Company (2016-2018) (K Pcs)

Table Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Company (2016-2018)

Figure Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Company in 2017

Table Actavis Company Details

Table Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Actavis Recent Development

Table F. Hoffmann-La Roche Company Details

Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table F. Hoffmann-La Roche Recent Development

Table Gilead Sciences Company Details

Table Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Gilead Sciences Recent Development

Table Novartis Company Details

Table Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Novartis Recent Development

Table Vertex Pharmaceuticals Company Details

Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Vertex Pharmaceuticals Recent Development

Table Abbott Company Details

Table Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Abbott Recent Development

Table Anthera Pharmaceuticals Company Details

Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Anthera Pharmaceuticals Recent Development

Table Arcturus Therapeutics Company Details

Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Arcturus Therapeutics Recent Development

Table Boehringer Ingelheim Company Details

Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Boehringer Ingelheim Recent Development

Table Chiesi Farmaceutici Company Details

Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Chiesi Farmaceutici Recent Development

Table Corbus Pharmaceuticals Company Details

Table Genzyme Company Details

Table Insmed Company Details

Table Johnson & Johnson Company Details

Table Merck Sharp & Dohme Company Details

Table Neovii Biotech Company Details

Table Novo Nordisk Company Details

Table PharmaSwiss Company Details

Table Pharmaxis Company Details

Table Proteostasis Therapeutics Company Details

Table PTC Therapeutics Company Details

Table United Medical Company Details

Table Venus Remedies Company Details

Figure GDP by Regions / Largest Economies Pie Chart in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Table Cystic Fibrosis Drugs Value Chain

Table Typical Suppliers of Key Cystic Fibrosis Drugs Raw Material

Table Cystic Fibrosis Drugs Customers List

Table Cystic Fibrosis Drugs Sales Channels

Table Cystic Fibrosis Drugs Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370